Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells

by Strieter Robert, Figlin Robert, Escuadro Brian, Luo Jie, Yang Seok, Batra Raj K, Baratelli Felicita, Riedl Karen, Sharma Sherven, Dubinett Steven
Published 2003-11-01

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

by Sharma Sherven, Batra Raj K, Zeng Gang, Kurimoto Pam S, Luo Jie, Peebles Katherine, Hazra Saswati, Takedatsu Hiroko, Baratelli Felicita, Dubinett Steven M, Lee Jay M
Published 2008-07-01

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10

by Batra Raj K, Huang Min, Zhu Li X, Hillinger Sven, Yang Seok-Chul, Sharma Sherven, Lin Jeff F, Burdick Marie D, Strieter Robert M, Dubinett Steven M
Published 2003-04-01

Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

by Gabbita S, Srivastava Minu K, Eslami Pirooz, Johnson Ming F, Kobritz Naomi K, Tweedie David, Greig Nigel H, Zemlan Frank P, Sharma Sherven P, Harris-White Marni E
Published 2012-05-01